Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Drug symbols : Alpmy save search
Takeda, Astellas and Sumitomo Mitsui Banking Announce Master Agreement to Establish Joint Venture Company for Incubation of Early Drug Discovery Programs
Published: 2024-04-22 (Crawled : 09:00) - prnewswire.com
SMFNF | News | $55.63 -1.2% 24K
|
Finance
|
| O: -0.16%
H: 3.14%
C: 0.04%
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: 0.63%
H: 0.0%
C: -0.31%
TAK | News | $13.23 -1.12% 0.0% 920K
|
Health Technology
|
| O: 0.8%
H: 0.75%
C: 0.38%
drug company for agreement
FDA Grants Orphan Drug and Pediatric Exclusivities for CRESEMBA® (isavuconazonium sulfate) for Invasive Aspergillosis and Invasive Mucormycosis in Children
Published: 2024-03-11 (Crawled : 13:00) - prnewswire.com
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: -1.41%
H: 5.06%
C: 4.01%
cresemba fda drug children grants
NeoPhore raises an additional £9.6m (USD $12.2m) Series B financing extension to further progress drug discovery pipeline
Published: 2024-02-01 (Crawled : 09:00) - prnewswire.com
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: -0.86%
H: 3.34%
C: 0.43%
drug pipeline series extension
Astellas Submits Supplemental New Drug Application in Japan for PADCEV™ (enfortumab vedotin (genetical recombination)) with KEYTRUDA® (pembrolizumab (genetical recombination)) for First-Line Treatment of Advanced Bladder Cancer
Published: 2024-01-31 (Crawled : 02:00) - prnewswire.com
ALPMF | News | $9.5 43.47% 1.2K
|
Health Technology
|
| O: 4.34%
H: 0.0%
C: 0.0%
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: 0.0%
H: 1.38%
C: 0.26%
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: 0.56%
H: 1.25%
C: -0.33%
keytruda drug japan bladder cancer treatment application advanced
Kadcyla Leads the Global Antibody Drug Conjugates Market with Extensive Use in Breast Cancer Treatment
Published: 2023-11-01 (Crawled : 18:00) - prnewswire.com
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: -1.46%
H: 3.67%
C: 3.26%
ZYME | $8.555 -0.06% -0.06% 590K
|
Health Technology
|
| O: 1.14%
H: 0.42%
C: -0.7%
TAK | News | $13.23 -1.12% 0.0% 920K
|
Health Technology
|
| O: 1.03%
H: 0.73%
C: 0.58%
ADCT | $4.78 -3.82% 0.0% 280K
|
Health Technology
|
| O: -0.16%
H: 6.42%
C: 4.49%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -0.86%
H: 0.0%
C: 0.0%
STRO | $3.47 -6.72% -7.2% 540K
|
Health Technology
|
| O: 0.39%
H: 3.86%
C: 3.86%
IMGN | News | $31.23 0.03% 49M
|
Health Technology
|
| O: 5.09%
H: 5.48%
C: -1.27%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: -0.47%
H: 1.88%
C: 1.78%
EXEL | $23.7 1.76% 1.73% 1.5M
|
Health Technology
|
| O: -2.62%
H: 1.17%
C: -1.66%
drug antibody breast cancer treatment global market
Hepatitis C Disease Market: Clinical Trial, Drug Development, Clinical Viewpoints, and Drug Insights| Disease Landscape Insights
Published: 2023-10-12 (Crawled : 14:30) - prnewswire.com
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: -2.72%
H: 2.65%
C: 2.12%
hepatitis drug disease
Reshaping Cystic Fibrosis Disease Landscape Report | Epidemiology Study, Drug Insights, Unmet Needs Analysis, KOL Perspectives Product Launch Services, and Regulatory Consulting |Disease Landscape Insights
Published: 2023-10-09 (Crawled : 09:00) - prnewswire.com
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: -0.04%
H: 0.77%
C: 0.7%
drug disease report fibrosis
Gene Therapy Market size is set to grow by USD 4,613.9 million from 2022 to 2027; Increase in special drug designations boosts the market growth - Technavio
Published: 2023-06-12 (Crawled : 15:00) - prnewswire.com
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: -0.68%
H: 3.23%
C: 1.55%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -0.16%
H: 0.11%
C: -0.76%
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: 0.62%
H: 4.57%
C: 2.04%
GBIO | News | $2.995 -8.13% -8.85% 110K
|
Health Technology
|
| O: 0.0%
H: 11.57%
C: 6.4%
BIIB | $201.91 4.52% 4.32% 3.3M
|
Health Technology
|
| O: 3.52%
H: 0.0%
C: -1.99%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: 0.22%
H: 0.0%
C: -0.86%
ADAP | $1.085 -4.83% -5.07% 780K
|
Health Technology
|
| O: -0.75%
H: 7.14%
C: 6.12%
ABEO | News | $3.165 -7.19% -7.74% 2.2M
|
Health Technology
|
| O: 0.0%
H: 4.4%
C: 3.29%
drug set therapy growth market
Astellas Submits New Drug Application for Zolbetuximab in Japan
Published: 2023-06-09 (Crawled : 04:00) - prnewswire.com
ALPMF | News | $9.5 43.47% 1.2K
|
Health Technology
|
| O: 0.46%
H: 0.0%
C: 0.0%
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: 0.81%
H: 0.0%
C: -0.06%
drug japan application
Gene therapy market size to grow by USD 4,613.9 million from 2022 to 2027; The increase in special drug designations to drive growth- Technavio
Published: 2023-03-16 (Crawled : 02:00) - prnewswire.com
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: 1.16%
H: 0.73%
C: 0.73%
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: 0.44%
H: 0.29%
C: 0.29%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.18%
H: 0.77%
C: 0.64%
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: -4.62%
H: 4.44%
C: -6.05%
GBIO | News | $2.995 -8.13% -8.85% 110K
|
Health Technology
|
| O: -0.55%
H: 6.69%
C: 1.95%
BIIB | $201.91 4.52% 4.32% 3.3M
|
Health Technology
|
| O: -1.11%
H: 2.97%
C: 2.23%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: -0.49%
H: 0.39%
C: 0.36%
ADAP | $1.085 -4.83% -5.07% 780K
|
Health Technology
|
| O: -2.65%
H: 14.55%
C: 9.09%
ABEO | News | $3.165 -7.19% -7.74% 2.2M
|
Health Technology
|
| O: -2.29%
H: 3.52%
C: -0.78%
drug therapy market
Astellas Provides Update on Fezolinetant New Drug Application in U.S.
Published: 2023-02-19 (Crawled : 00:00) - prnewswire.com
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
| Email alert
Add to watchlist
ALPMF | News | $9.5 43.47% 1.2K
|
Health Technology
| Email alert
Add to watchlist
drug application update
Astellas and MBC BioLabs Announce Astellas Future Innovator Prize to Help Biotech Start-ups Accelerate Early Drug Discovery and Research Efforts
Published: 2022-09-20 (Crawled : 02:00) - prnewswire.com
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: -0.51%
H: 0.07%
C: -0.29%
drug research biotech
Worldwide Irritable Bowel Syndrome with Constipation Drugs Industry to 2030 - by Drug Type, Prescription Type and Region
Published: 2022-09-15 (Crawled : 18:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 1.6%
H: 0.0%
C: -6.5%
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: 0.97%
H: 0.0%
C: -3.99%
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: 0.22%
H: 0.14%
C: -0.43%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: 0.26%
H: 0.96%
C: -0.94%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.4%
H: 0.84%
C: 0.37%
IRWD | $8.11 -2.41% -2.47% 1.9M
|
Health Technology
|
| O: 0.0%
H: 0.72%
C: -1.27%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: -0.19%
H: 0.09%
C: -0.8%
ARDX | $6.43 0.63% 0.62% 5.4M
|
Health Technology
|
| O: -2.9%
H: 3.73%
C: 2.24%
drug
U.S. FDA Accepts Astellas' New Drug Application for Fezolinetant
Published: 2022-08-18 (Crawled : 07:00) - prnewswire.com
ALPMF | News | $9.5 43.47% 1.2K
|
Health Technology
|
| O: 2.87%
H: 0.0%
C: 0.0%
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: -0.8%
H: 0.33%
C: -0.8%
fda drug application
Astellas and Sutro Biopharma Announce Worldwide Strategic Collaboration to Advance Novel Immunostimulatory Antibody-Drug Conjugates (iADCs)
Published: 2022-06-27 (Crawled : 00:00) - globenewswire.com
ALPMF | News | $9.5 43.47% 1.2K
|
Health Technology
|
| O: 5.56%
H: 0.0%
C: 0.0%
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: 1.88%
H: 0.0%
C: -0.68%
STRO | $3.47 -6.72% -7.2% 540K
|
Health Technology
|
| O: 15.01%
H: 14.86%
C: 5.02%
collaboration drug
Rheumatoid Arthritis Drugs Market Size to Grow by USD 14.90 Billion | 37% of the growth will originate from Europe | Technavio
Published: 2022-06-24 (Crawled : 09:00) - prnewswire.com
ALPMF | News | $9.5 43.47% 1.2K
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: -0.5%
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: 3.19%
H: 2.28%
C: -1.81%
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 8.01%
H: 0.0%
C: 0.0%
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: 6.71%
H: 0.0%
C: -0.1%
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: 4.33%
H: 0.0%
C: -2.44%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 2.38%
H: 0.0%
C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 1.26%
H: 0.95%
C: 0.92%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 1.57%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 3.49%
H: 0.0%
C: 0.0%
GLMD | $0.3852 6.59% 6.18% 52K
|
Health Technology
|
| O: 1.21%
H: 0.0%
C: -3.5%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: 0.37%
H: 0.82%
C: 0.56%
europe growth market drug
Astellas Submits Fezolinetant New Drug Application to U.S. FDA
Published: 2022-06-23 (Crawled : 00:00) - prnewswire.com
ALPMF | News | $9.5 43.47% 1.2K
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: -0.5%
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: 4.33%
H: 0.0%
C: -2.44%
fda drug application
Insights on the Psoriasis Therapeutics Global Market to 2028 - Cumulative Development of New Biologics and New Pipeline Drugs Presents Opportunities
Published: 2022-06-20 (Crawled : 15:20) - prnewswire.com
ALPMF | News | $9.5 43.47% 1.2K
|
Health Technology
| Email alert
Add to watchlist
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
| Email alert
Add to watchlist
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
| Email alert
Add to watchlist
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
| Email alert
Add to watchlist
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
| Email alert
Add to watchlist
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
| Email alert
Add to watchlist
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
| Email alert
Add to watchlist
therapeutics psoriasis market drug
ExCellThera announces submission of Drug Master File for UM171
Published: 2022-06-17 (Crawled : 14:00) - biospace.com/
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: -1.34%
H: 0.2%
C: -0.61%
um171 drug submission
Global Genitourinary Drugs Market Research Report to 2027 - Increasing Prevalence of Genitourinary Disorders is Driving Growth
Published: 2022-04-26 (Crawled : 14:00) - prnewswire.com
ALPMF | News | $9.5 43.47% 1.2K
|
Health Technology
|
| O: 2.56%
H: 0.0%
C: 0.0%
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: 0.13%
H: 0.06%
C: -0.69%
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: 3.08%
H: 0.0%
C: 0.0%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.47%
H: 0.83%
C: -1.44%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 2.0%
H: 0.0%
C: 0.0%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.34%
H: 1.41%
C: -1.17%
IONS | $42.455 1.47% 1.45% 730K
|
Health Technology
|
| O: -0.12%
H: 0.07%
C: -5.13%
research report growth market drug
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.